Zacks Investment Management’s HilleVax HLVX Stock Holding History

Zacks Investment Management’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-92,803	Closed	-$185K	–	797
2025 Q2	$185K	Hold	92,803	–	–	﹤0.01%	648
2025 Q1	$135K	Hold	92,803	–	–	﹤0.01%	625
2024 Q4	$192K	Hold	92,803	–	–	﹤0.01%	633
2024 Q3	$163K	Buy	92,803 +74,673	+412%	+$191K	﹤0.01%	648
2024 Q2	$262K	Hold	18,130	–	–	﹤0.01%	533
2024 Q1	$302K	Buy	+18,130	New	+$290K	﹤0.01%	540

Zacks Investment Management's HLVX Position: Q3 2025 in Review

Zacks Investment Management sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 92,803 shares — an estimated $185K sold.

Zacks Investment Management first reported a position in HLVX in Q1 2024 and held it in 6 quarters. The position peaked at $302K in Q1 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

Zacks Investment Management reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
Zacks Investment Management sold 92,803 HilleVax shares in Q3 2025, an estimated $185K.
Zacks Investment Management first reported a position in HilleVax in Q1 2024 and held it in 6 quarters.
Zacks Investment Management's HilleVax position peaked at $302K in Q1 2024.
1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Zacks Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.